AssetMark Inc
COLL icon

AssetMark Inc’s Collegium Pharmaceutical COLL Stock Holding History

AssetMark Inc’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
6,013
+2,090
+53% +$71.4K ﹤0.01% 1416
2026
Q1 		$130K Buy
3,923
+335
+9% +$14.2K ﹤0.01% 1458
2025
Q4 		$166K Sell
3,588
-963
-21% -$40.3K ﹤0.01% 1345
2025
Q3 		$159K Buy
4,551
+352
+8% +$12.2K ﹤0.01% 1321
2025
Q2 		$124K Sell
4,199
-310
-7% -$8.84K ﹤0.01% 1322
2025
Q1 		$135K Sell
4,509
-180
-4% -$5.5K ﹤0.01% 1222
2024
Q4 		$134K Sell
4,689
-202
-4% -$6.68K ﹤0.01% 1189
2024
Q3 		$189K Sell
4,891
-524
-10% -$18.7K ﹤0.01% 1025
2024
Q2 		$174K Buy
5,415
+514
+10% +$17.8K ﹤0.01% 1024
2024
Q1 		$190K Sell
4,901
-544
-10% -$19K ﹤0.01% 950
2023
Q4 		$168K Buy
5,445
+1,108
+26% +$27.8K ﹤0.01% 951
2023
Q3 		$96.9K Buy
4,337
+281
+7% +$6.41K ﹤0.01% 993
2023
Q2 		$87.2K Buy
4,056
+1,231
+44% +$27.9K ﹤0.01% 976
2023
Q1 		$67.8K Buy
2,825
+885
+46% +$23.5K ﹤0.01% 967
2022
Q4 		$45K Buy
1,940
+264
+16% +$5.32K ﹤0.01% 1067
2022
Q3 		$27K Buy
1,676
+575
+52% +$10.1K ﹤0.01% 1074
2022
Q2 		$20K Buy
1,101
+646
+142% +$10.9K ﹤0.01% 1114
2022
Q1 		$9K Buy
+455
New +$8.6K ﹤0.01% 1201

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

AssetMark Inc's COLL Position: Q2 2026 in Review

AssetMark Inc increased its Collegium Pharmaceutical (COLL) stake by 53% in Q2 2026, buying an estimated $71.4K and bringing the position to 6,013 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

AssetMark Inc first reported a position in COLL in Q1 2022 and has held it in 18 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • AssetMark Inc held 6,013 shares of Collegium Pharmaceutical worth $218K as of Q2 2026.
  • AssetMark Inc bought 2,090 Collegium Pharmaceutical shares in Q2 2026, an estimated $71.4K.
  • Collegium Pharmaceutical made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1416 holding.
  • AssetMark Inc first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.